{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:43:48Z","timestamp":1785807828946,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.thromres.2024.109060","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:03:25Z","timestamp":1717675405000},"page":"109060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting"],"prefix":"10.1016","volume":"240","author":[{"given":"Alba","family":"Ant\u00fanez-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pozo-Agundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Gabriel","family":"S\u00e1nchez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Moreno-Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mat\u00edas","family":"Trivi\u00f1o-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Javier","family":"Mart\u00ednez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Luc\u00eda","family":"D\u00e1vila-Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2024.109060_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40265-015-0375-0","article-title":"Clinical association between pharmacogenomics and adverse drug reactions","volume":"75","author":"Zhou","year":"2015","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40262-015-0324-9","article-title":"Impact of new genomic technologies on understanding adverse drug reactions","volume":"55","author":"Maggo","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"10374","key":"10.1016\/j.thromres.2024.109060_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2024.109060_bb0020","first-page":"239","article-title":"Clinical utility of CYP2C19 genotype-guided antiplatelet therapy in patients at risk of adverse cardiovascular and cerebrovascular events: a review of emerging evidence","volume":"13","author":"Gower","year":"2020","journal-title":"Pharmgenomics Pers. Med."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00228-021-03224-8","article-title":"Utility of a pharmacogenetic-driven algorithm in guiding dual antiplatelet therapy for patients undergoing coronary drug-eluting stent implantation in China","volume":"78","author":"Lyu","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.thromres.2024.109060_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrcardio.2017.18","article-title":"Antithrombotic therapy for patients with STEMI undergoing primary PCI","volume":"14","author":"Franchi","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.thromres.2024.109060_bb0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","article-title":"Current concepts and novel targets for antiplatelet therapy","volume":"20","author":"Gawaz","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.kint.2016.09.014","article-title":"Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease","volume":"91","author":"Carrero","year":"2017","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/17512433.2017.1353909","article-title":"Role of genetic testing in patients undergoing percutaneous coronary intervention","volume":"11","author":"Moon","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"9749","key":"10.1016\/j.thromres.2024.109060_bb0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(10)61273-1","article-title":"Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis","volume":"376","author":"Mega","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.thromres.2024.109060_bb0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1080\/14740338.2020.1836152","article-title":"Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: a systematic review","volume":"19","author":"Biswas","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"issue":"17","key":"10.1016\/j.thromres.2024.109060_bb0060","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2018.02.029","article-title":"Pharmacogenomic approach to selecting antiplatelet therapy in patients with acute coronary syndromes: the PHARMCLO trial","volume":"71","author":"Notarangelo","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.thromres.2024.109060_bb0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.2020.12443","article-title":"Effect of genotype-guided Oral P2Y12 inhibitor selection vs conventional Clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial","volume":"324","author":"Pereira","year":"2020","journal-title":"JAMA - J Am Med Assoc."},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0070","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.ijcard.2013.06.014","article-title":"Personalized antiplatelet therapy according to CYP2C19 genotype after percutaneous coronary intervention: a randomized control trial","volume":"168","author":"Xie","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2024.109060_bb0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2016.09.088","article-title":"Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent","volume":"225","author":"S\u00e1nchez-Ramos","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.thromres.2024.109060_bb0080","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cpt.1911","article-title":"Genome-wide association study of platelet reactivity and cardiovascular response in patients treated with Clopidogrel: a study by the international Clopidogrel pharmacogenomics consortium","volume":"108","author":"Verma","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.thromres.2024.109060_bb0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/eurheartj\/ehv122","volume":"36","author":"Mogensen","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","author":"Whirl-Carrillo","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2024.109060_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.dib.2016.12.019","article-title":"The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent","volume":"10","author":"D\u00e1vila-Fajardo","year":"2016","journal-title":"Data Br."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1021055617738","article-title":"DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping","volume":"33","author":"Freeman","year":"2003","journal-title":"Behav. Genet."},{"key":"10.1016\/j.thromres.2024.109060_bb0105","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.chemosphere.2015.07.079","article-title":"Polymorphisms of pesticide-metabolizing genes in children living in intensive farming communities","volume":"139","author":"G\u00f3mez-Mart\u00edn","year":"2015","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.thromres.2024.109060_bb0110","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cpt.589","article-title":"Genomewide association study identifies novel genetic loci that modify antiplatelet effects and pharmacokinetics of Clopidogrel","volume":"101","author":"Zhong","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2024.109060_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103249","article-title":"The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation","volume":"65","author":"Panera","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.thromres.2024.109060_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","article-title":"Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease","volume":"122","author":"Van der Harst","year":"2018","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/07853890.2017.1392595","article-title":"Next generation sequencing applications for cardiovascular disease","volume":"50","author":"Kalayinia","year":"2018","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.thromres.2024.109060_bb0130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/cpt.532","article-title":"Targeted next-generation sequencing for comprehensive genetic profiling of Pharmacogenes","volume":"101","author":"Han","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0135","first-page":"81","article-title":"Targeted next generation sequencing as a tool for precision medicine","volume":"12","author":"Gulilat","year":"2019","journal-title":"BMC Med. Genet."},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0140","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/molecules22040589","article-title":"ABC transport proteins in cardiovascular disease - a brief summary","volume":"22","author":"Schumacher","year":"2017","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/pr.119.017897","article-title":"Brothers in arms: ABCA1-and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatments","volume":"72","author":"Frambach","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0150","article-title":"Association of rs2230806 in ABCA1 with coronary artery disease: an updated meta-analysis based on 43 research studies","volume":"99","author":"Fan","year":"2020","journal-title":"Med."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1034\/j.1399-0004.2002.610206.x","article-title":"ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels","volume":"61","author":"Zwarts","year":"2002","journal-title":"Clin. Genet."},{"key":"10.1016\/j.thromres.2024.109060_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yjmcc.2014.04.017","article-title":"Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction","volume":"74","author":"Suresh","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.thromres.2024.109060_bb0165","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport: basic mechanisms and their roles in vascular health and disease","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.thromres.2024.109060_bb0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13105-021-00870-5","article-title":"A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux","volume":"78","author":"Guo","year":"2022","journal-title":"J. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.thromres.2024.109060_bb0175","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.3390\/nu11112588","article-title":"Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review","volume":"11","author":"Chambers","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14952","article-title":"FGF21\/FGFR1-\u03b2-KL cascade in cardiomyocytes modulates angiogenesis and inflammation under metabolic stress","volume":"9","author":"Kaur","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41598-021-00906-2","article-title":"Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.thromres.2024.109060_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1150222","article-title":"Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho","volume":"14","author":"Aaldijk","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28890","article-title":"Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart","volume":"65","author":"Desai","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0205","first-page":"261","article-title":"The role of bile acids in cardiovascular diseases: from mechanisms to clinical implications","volume":"14","author":"Zhang","year":"2023","journal-title":"Aging Dis."},{"issue":"6","key":"10.1016\/j.thromres.2024.109060_bb0210","doi-asserted-by":"crossref","first-page":"H1029","DOI":"10.1152\/ajpheart.00527.2015","article-title":"Fibroblast growth factors in cardiovascular disease: the emerging role of FGF21","volume":"309","author":"Domouzoglou","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.thromres.2024.109060_bb0215","article-title":"Participant-derived cell line transcriptomic analyses and mouse studies reveal a role for ZNF335 in plasma cholesterol statin response","author":"Theusch","year":"2023","journal-title":"bioRxiv [Preprint]"},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCRESAHA.118.312436","article-title":"Genetics of thoracic and abdominal aortic diseases: aneurysms, dissections, and ruptures Am\u00e9lie","volume":"124","author":"Pinard","year":"2019","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCRESAHA.115.306629","article-title":"Identifying novel gene variants in coronary artery disease and shared genes with several cardiovascular risk factors","volume":"118","author":"LeBlanc","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0230","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/CIRCRESAHA.116.308765","article-title":"Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci","volume":"120","author":"Jones","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.109060_bb0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.thromres.2024.109060_bb0240","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.3390\/ijms22063180","article-title":"Lipids and antiplatelet therapy: important considerations and future perspectives","volume":"22","author":"\u00d0ukanovi\u0107","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0245","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/biomedicines10020259","article-title":"Comprehensive statistical and bioinformatics analysis in the deciphering of putative mechanisms by which lipid-associated GWAS loci contribute to coronary artery disease","volume":"10","author":"Lazarenko","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.thromres.2024.109060_bb0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","article-title":"Pharmacogenomics: current status and future perspectives","volume":"24","author":"Pirmohamed","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.thromres.2024.109060_bb0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrg2751","article-title":"Genome-wide association studies in pharmacogenomics","volume":"11","author":"Daly","year":"2010","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.thromres.2024.109060_bb0260","article-title":"From pharmacogenetics to pharmaco-omics: milestones and future directions","volume":"3","author":"Auwerx","year":"2022","journal-title":"Hum. Genet. Genomics Adv."},{"key":"10.1016\/j.thromres.2024.109060_bb0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2019.01.024","article-title":"Prediction of drug response and adverse drug reactions: from twin studies to next generation sequencing","volume":"130","author":"Lauschke","year":"2019","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T22:02:37Z","timestamp":1720044157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":53,"alternative-id":["S0049384824001920"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109060","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109060"}}